Trial ID or NCT#

NCT02420379

Status

recruiting iconRECRUITING

Purpose

This is an open-label study to assess the safety, tolerability, efficacy and pharmacokinetics of eteplirsen in patients with early stage Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.

 

Investigator(s)

John Day, MD, PhD

Contact us to find out if this trial is right for you.

CONTACT

Shirley Paulose
(650) 724-3792